BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12638038)

  • 1. Percutaneous interventions in radiation-associated coronary in-stent restenosis.
    Wexberg P; Beran G; Lang I; Siostrzonek P; Kirisits C; Glogar D; Gottsauner-Wolf M
    Cardiovasc Intervent Radiol; 2003; 26(2):154-7. PubMed ID: 12638038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
    Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compassionate use of intracoronary beta-irradiation for treatment of recurrent in-stent restenosis.
    Sabaté M; Kay IP; Gijzel AL; Wardeh AJ; Van der Giessen WJ; Coen VL; Ligthart JM; Costa MA; Kozuma K; Serrano P; Levendag PC; Serruys PW
    J Invasive Cardiol; 1999 Sep; 11(9):582-8. PubMed ID: 10745603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study.
    Ribichini F; Ferrero V; Rognoni A; Marino P; Brunelleschi S; Vassanelli C
    J Interv Cardiol; 2007 Apr; 20(2):114-21. PubMed ID: 17391219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.
    Geiger MH; Ludwig J; Burckhard R; Scheinert D; Müller RG; Daniel WG; Sauer R; Strnad V
    Strahlenther Onkol; 2006 Jan; 182(1):9-15. PubMed ID: 16404515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon-based radiation therapy for treatment of in-stent restenosis in human coronary arteries: results from the BRITE I study.
    Waksman R; Buchbinder M; Reisman M; Lansky AJ; Trauthen B; Whiting J; Li A
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):286-94. PubMed ID: 12410499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
    Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P
    Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracoronary beta-radiotherapy in high-risk in-stent restenosis. Prospective results of a single center registry].
    Ortolani P; Marzocchi A; Gaiba W; Neri S; Marrozzini C; Palmerini T; Aquilina M; Corlianò L; Lombardo E; Bunkheila F; Pini S; Sbarzaglia P; Taglieri N; Barbieri E; Branzi A
    Ital Heart J Suppl; 2003 Aug; 4(8):672-81. PubMed ID: 14655463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.